Correlation Between Precision BioSciences and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Candel Therapeutics, you can compare the effects of market volatilities on Precision BioSciences and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Candel Therapeutics.
Diversification Opportunities for Precision BioSciences and Candel Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Precision and Candel is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Precision BioSciences and Candel Therapeutics
Given the investment horizon of 90 days Precision BioSciences is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Precision BioSciences is 1.41 times less risky than Candel Therapeutics. The stock trades about -0.27 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 519.00 in Candel Therapeutics on September 5, 2024 and sell it today you would lose (68.00) from holding Candel Therapeutics or give up 13.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Precision BioSciences vs. Candel Therapeutics
Performance |
| Timeline |
| Precision BioSciences |
| Candel Therapeutics |
Precision BioSciences and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Precision BioSciences and Candel Therapeutics
The main advantage of trading using opposite Precision BioSciences and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Precision BioSciences vs. X4 Pharmaceuticals | Precision BioSciences vs. Acumen Pharmaceuticals | Precision BioSciences vs. Inozyme Pharma | Precision BioSciences vs. Terns Pharmaceuticals |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |